Skip to content 
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified. more
| Time Frame | CANC | S&P500 |
|---|---|---|
| 1-Week Return | -0.51% | 1.14% |
| 1-Month Return | -4.09% | 2.1% |
| 3-Month Return | -3.9% | 3.61% |
| 6-Month Return | 7.68% | 14.49% |
| 1-Year Return | 36.03% | 15.96% |
| 3-Year Return | 77.65% | 80.16% |
| 5-Year Return | 1020.41% | 79.09% |
| Stock name | Ticker | Weight |
|---|---|---|
 REVOLUTION MEDICINES INC | RVMD | 5.38% |
 MERCK & CO INC | MRK | 5.24% |
 COGENT BIOSCIENCES INC | COGT | 4.69% |
 ELI LILLY & CO | LLY | 4.62% |
 NOVARTIS AG | NOVN.SW | 3.78% |
 GENMAB A/S | GMAB | 3.68% |
 ABBVIE INC | ABBV | 3.59% |
 BEONE MEDICINES LTD | ONC | 3.47% |
 IOVANCE BIOTHERAPEUTICS INC | IOVA | 3.37% |
 EXELIXIS INC | EXEL | 3.26% |
 HALOZYME THERAPEUTICS INC | HALO | 3.18% |
 BRISTOL-MYERS SQUIBB CO | BMY | 3.09% |
 BRIDGEBIO PHARMA INC | BBIO | 2.68% |
 ROCHE HOLDING AG | RHHBY | 2.66% |
 IDEAYA BIOSCIENCES INC | IDYA | 2.58% |
 IMMUNOME INC | IMNM | 2.52% |
 JOHNSON & JOHNSON | JNJ | 2.5% |
 CG ONCOLOGY INC | CGON | 2.49% |
 ENLIVEN THERAPEUTICS INC | ELVN | 2.33% |
 ERASCA INC | ERAS | 2.13% |
 ASTRAZENECA PLC | AZN.L | 2.07% |
 RELAY THERAPEUTICS INC | RLAY | 1.98% |
 ZAI LAB LTD | ZLAB | 1.88% |
 LEGEND BIOTECH CORP | LEGN | 1.85% |
 SUMMIT THERAPEUTICS INC | SMMT | 1.84% |
 CELCUITY INC | CELC | 1.46% |
 AMGEN INC | AMGN | 1.34% |
 ZYMEWORKS INC | ZYME | 1.28% |
 NATERA INC | NTRA | 1.22% |
 KURA ONCOLOGY INC | KURA | 1.12% |
 IMMUNITYBIO INC | IBRX | 1.1% |
 ARCUS BIOSCIENCES INC | RCUS | 1.07% |
 NUVATION BIO INC | NUVB | 1.05% |
 GILEAD SCIENCES INC | GILD | 1.01% |
 UROGEN PHARMA LTD | URGN | 0.96% |
 ADLAI NORTYE GROUP LTD | ANL | 0.77% |
 CORVUS PHARMACEUTICALS INC | CRVS | 0.75% |
 GUARDANT HEALTH INC | GH | 0.74% |
 REPLIMUNE GROUP INC | REPL | 0.73% |
 INHIBRX BIOSCIENCES INC | INBX | 0.67% |
 ORIC PHARMACEUTICALS INC | ORIC | 0.67% |
 TANGO THERAPEUTICS INC | TNGX | 0.67% |
 IMMUNOCORE HOLDINGS PLC | IMCR | 0.66% |
 VERASTEM INC | VSTM | 0.53% |
 IMMATICS NV | IMTX | 0.53% |
 JANUX THERAPEUTICS INC | JANX | 0.5% |
 MODERNA INC | MRNA | 0.48% |
 CULLINAN THERAPEUTICS INC | CGEM | 0.46% |
 CASH & CASH EQUIVALENTS | CASH...CASH.EQUIVALENTS | 0.46% |
 CANDEL THERAPEUTICS INC | CADL | 0.43% |
 ANAPTYSBIO INC | ANAB | 0.42% |
 BICARA THERAPEUTICS INC | BCAX | 0.33% |
 OLEMA PHARMACEUTICALS INC | OLMA | 0.33% |
 CYTOMX THERAPEUTICS INC | CTMX | 0.31% |
 ARRIVENT BIOPHARMA INC | AVBP | 0.3% |
 TYRA BIOSCIENCES INC | TYRA | 0.28% |
 AUTOLUS THERAPEUTICS PLC | AUTL | 0.24% |
 ARVINAS INC | ARVN | 0.23% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
Tema Oncology ETF (CANC) share price today is $40.615.
Yes, Indians can buy shares of Tema Oncology ETF (CANC) on Vested. To buy CANC from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Tema Oncology ETF (CANC) on Vested. You can start investing in Tema Oncology ETF (CANC) with a minimum investment of $1.
The 52-week high price of Tema Oncology ETF (CANC) is $47. The 52-week low price of Tema Oncology ETF (CANC) is $29.26.
The stock symbol (or ticker) of Tema Oncology ETF is CANC.
Yes, you can setup SIP in Tema Oncology ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of CANC on the Vested app.
The expense ratio of Tema Oncology ETF (CANC) is 0.78%.
Link copied 
